Effects of an anti-IL-10 monoclonal antibody on rIFNβ-1b-mediated immune modulation. Relevance to multiple sclerosis
- 31 January 1998
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 81 (1-2) , 109-115
- https://doi.org/10.1016/s0165-5728(97)00165-3
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Interferon β decreases T cell activation and interferon γ production in multiple sclerosisJournal of Neuroimmunology, 1993
- Tumor necrosis factor inhibits K+ current expression in cultured oligodendrocytesThe Journal of Membrane Biology, 1991
- Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.The Journal of Experimental Medicine, 1991
- Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.The Journal of Experimental Medicine, 1991
- Virus-induced interferon αβ (IFN-αβ) production by T cells and by Th1 and Th2 helper T cell clones: A study of the immunoregulatory actions of IFN-γ versus IFN-αβ on functions of different T cell populationsCellular Immunology, 1990
- Multiple sclerosis: Involvement of interferons in lesion pathogenesisAnnals of Neurology, 1988
- Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitroAnnals of Neurology, 1988
- Interleukin-1 Stimulation of Astroglial Proliferation After Brain InjuryScience, 1985
- New diagnostic criteria for multiple sclerosis: Guidelines for research protocolsAnnals of Neurology, 1983
- Interferon as a mediator of human lymphocyte suppression.The Journal of Experimental Medicine, 1980